1652.HK Stock Analysis
16
Uncovered
Fusen Pharmaceutical Co Ltd is uncovered by Eyestock quantitative analysis.
Rating
To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.
Low score
Fusen Pharmaceutical Co., Ltd. manufactures pharmaceuticals and medical devices. The company is headquartered in Nanyang, Henan and currently employs 1,143 full-time employees. The company went IPO on 2018-07-11. The firm is mainly engaged in research, development, production and sales of Chinese patent drugs and western medicine products for the treatment of cold and fever, cardiovascular diseases and anemia. The firm's main products include small volume injections, oral liquids, tablets, capsules and granules. The firm distributes its products mainly in domestic market.